What it is

Epitalon (often spelled epithalon) is a short peptide associated with pineal biology in parts of the gerontology literature.

Online, it’s frequently marketed as a sleep and “anti-aging” peptide. In the peer-reviewed literature, one of the more concrete themes is experiments related to telomerase and telomere length.

Why people care

The internet version of the story is usually:

improved sleep and circadian rhythm
anti-aging via telomeres

The reality is more mixed: there are intriguing mechanistic papers and reviews, but the strongest, most direct human-outcome evidence for many of the boldest claims is limited.

Evidence landscape

Cell and mechanistic studies exist, including work reporting telomerase/telomere effects.
Some of the literature is older and/or in journals that are less commonly cited in mainstream clinical practice.

Safety reality

Epitalon is not an approved therapy for longevity or sleep, and there is no modern, large, well-characterized safety database for broad use. We do not provide dosing advice.

References

“Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties.” International Journal of Molecular Sciences (2025). https://pubmed.ncbi.nlm.nih.gov/40141333/
“Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity.” Biogerontology (2025). https://pubmed.ncbi.nlm.nih.gov/40908429/
“Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.” Bulletin of Experimental Biology and Medicine (2003). https://pubmed.ncbi.nlm.nih.gov/12937682/
“Peptide promotes overcoming of the division limit in human somatic cell.” Bulletin of Experimental Biology and Medicine (2004). https://pubmed.ncbi.nlm.nih.gov/15455129/